产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 | |||
| 1g | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 | |||
| 1g | 98% | 询价 |
CAS No. |
1282513-03-4 |
|---|---|
中文名称 |
2-(4-(2-(1-异丙基-3-甲基-1H-1,2,4-三唑-5-基)-5,6-二氢苯并[f]咪唑并[1,2 d] [1,4]氧氮杂-9-基)-1H-吡唑-1-基)-2-甲基丙酸 |
英文名称 |
2-(4-(2-(1-Isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid |
别名 |
1H-Pyrazole-1-acetic acid, 4-[5,6-dihydro-2-[3-Methyl-1-(1-Methylethyl)-1H-1,2,4-triazol-5-yl]iMidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-diMethyl-;2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid |
标准英文名 |
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid |
MDL No. |
MFCD28167893 |
分子式 |
C24H27N7O3 |
分子量 |
461.53 |
精确分子量 |
461.22 |
SMILES |
CC(C)(N1N=CC(C2=CC=C3C4=NC(C5=NC(C)=NN5C(C)C)=CN4CCOC3=C2)=C1)C(O)=O |
标准SMILES |
CC1N=C(C2=CN3CCOC4=CC(=CC=C4C3=N2)C2=CN(N=C2)C(C)(C)C(O)=O)N(N=1)C(C)C |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
DFLUNRVFVAAWSG-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|